1
|
PINK1-dependent recruitment of Parkin to mitochondria in mitophagy.
|
Proc Natl Acad Sci U S A
|
2009
|
8.25
|
2
|
Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease.
|
J Neurosci
|
2002
|
4.38
|
3
|
Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture.
|
Nat Neurosci
|
2010
|
3.38
|
4
|
NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
|
Proc Natl Acad Sci U S A
|
2003
|
2.91
|
5
|
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration.
|
Proc Natl Acad Sci U S A
|
2003
|
2.74
|
6
|
Glutathione dysregulation and the etiology and progression of human diseases.
|
Biol Chem
|
2009
|
2.70
|
7
|
Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP.
|
Proc Natl Acad Sci U S A
|
2002
|
2.64
|
8
|
Neuronal adenosine release, and not astrocytic ATP release, mediates feedback inhibition of excitatory activity.
|
Proc Natl Acad Sci U S A
|
2012
|
1.74
|
9
|
MPTP as a mitochondrial neurotoxic model of Parkinson's disease.
|
J Bioenerg Biomembr
|
2004
|
1.69
|
10
|
Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage.
|
Proc Natl Acad Sci U S A
|
2005
|
1.68
|
11
|
Perturbations in mitochondrial dynamics induced by human mutant PINK1 can be rescued by the mitochondrial division inhibitor mdivi-1.
|
J Biol Chem
|
2010
|
1.65
|
12
|
The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway.
|
Proc Natl Acad Sci U S A
|
2009
|
1.43
|
13
|
Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice.
|
J Neurosci
|
2005
|
1.40
|
14
|
Pathogenic role of glial cells in Parkinson's disease.
|
Mov Disord
|
2003
|
1.25
|
15
|
Silencing of the Pink1 gene expression by conditional RNAi does not induce dopaminergic neuron death in mice.
|
Int J Biol Sci
|
2007
|
1.20
|
16
|
Astrocytes and therapeutics for Parkinson's disease.
|
Neurotherapeutics
|
2010
|
1.18
|
17
|
Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3.
|
Proc Natl Acad Sci U S A
|
2011
|
1.03
|
18
|
Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin.
|
PLoS One
|
2013
|
0.92
|
19
|
D-β-hydroxybutyrate is protective in mouse models of Huntington's disease.
|
PLoS One
|
2011
|
0.92
|
20
|
Glial cell response: A pathogenic factor in Parkinson's disease.
|
J Neurovirol
|
2002
|
0.83
|
21
|
Cultured astrocytes do not release adenosine during hypoxic conditions.
|
J Cereb Blood Flow Metab
|
2011
|
0.82
|
22
|
Free radical and nitric oxide toxicity in Parkinson's disease.
|
Adv Neurol
|
2003
|
0.81
|
23
|
Neurosteroid transport by the organic solute transporter OSTα-OSTβ.
|
J Neurochem
|
2010
|
0.80
|